Your browser doesn't support javascript.
loading
Late Mortality in Childhood Cancer Survivors according to Pediatric Cancer Diagnosis and Treatment Era in the Dutch LATER Cohort.
Kilsdonk, Ellen; van Dulmen-den Broeder, Eline; van Leeuwen, Flora E; van den Heuvel-Eibrink, Marry M; Loonen, Jacqueline J; van der Pal, Helena J; Bresters, Dorine; Versluys, A B; Pieters, Rob; Hauptmann, Michael; Jaspers, Monique W M; Neggers, Sebastian J C; Raphael, Martine F; Tissing, Wim J E; Kremer, Leontine C M; Ronckers, Cécile M.
Afiliação
  • Kilsdonk E; Princess Maxima Center for Pediatric Oncology, Utrecht, The Netherlands.
  • van Dulmen-den Broeder E; Amsterdam UMC, Location AMC, Amsterdam, The Netherlands.
  • van Leeuwen FE; Princess Maxima Center for Pediatric Oncology, Utrecht, The Netherlands.
  • van den Heuvel-Eibrink MM; VU University Medical Center, Amsterdam, The Netherlands.
  • Loonen JJ; Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • van der Pal HJ; Princess Maxima Center for Pediatric Oncology, Utrecht, The Netherlands.
  • Bresters D; Erasmus Medical Center/Sophia Children's Hospital, Rotterdam, The Netherlands.
  • Versluys AB; Radboud University Medical Center, Nijmegen, The Netherlands.
  • Pieters R; Princess Maxima Center for Pediatric Oncology, Utrecht, The Netherlands.
  • Hauptmann M; UMC Amsterdam, Emma Children's Hospital/Academic Medical Center, Amsterdam, The Netherlands.
  • Jaspers MWM; Princess Maxima Center for Pediatric Oncology, Utrecht, The Netherlands.
  • Neggers SJC; Willem Alexander Children's Hospital/Leiden University Medical Center, Leiden, The Netherlands.
  • Raphael MF; Princess Maxima Center for Pediatric Oncology, Utrecht, The Netherlands.
  • Tissing WJE; University Medical Center Utrecht, Utrecht, The Netherlands.
  • Kremer LCM; Princess Maxima Center for Pediatric Oncology, Utrecht, The Netherlands.
  • Ronckers CM; Netherlands Cancer Institute, Amsterdam, The Netherlands.
Cancer Invest ; 40(5): 413-424, 2022 May.
Article em En | MEDLINE | ID: mdl-35175864
This multi-center cohort-study examined late mortality among 6,165 Dutch five-year childhood cancer survivors diagnosed 1963-2001. Clinical details and cause of death were based on medical records. Mortality was 12-fold that of the general population, with 51.3 additional deaths per 10,000 person-years (21.9 yrs median follow-up). Cumulative mortality 15 yrs post-diagnosis was 6.9%, predominantly from late recurrences; thereafter the absolute contribution of other health outcomes increased. Cumulative all-cause and recurrence-related mortality were highest for Central Nervous System and bone tumor survivors. All-cause, but not subsequent tumor and circulatory disease-related cumulative mortality, was highest for patients diagnosed 1963-1979 vs. later (p-trend <0.001).
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Sobreviventes de Câncer / Neoplasias Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limite: Child / Humans País/Região como assunto: Europa Idioma: En Revista: Cancer Invest Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Holanda

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Sobreviventes de Câncer / Neoplasias Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limite: Child / Humans País/Região como assunto: Europa Idioma: En Revista: Cancer Invest Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Holanda